Qingguo Tian1, Juan Rogness2, Min Meng2, Zheng Li1. 1. Bioanalysis, Arrowhead Pharmaceuticals, Inc., 502 S. Rosa Road, Madison, WI 53719, USA. 2. Bioanalytical lab, Covance Laboratories, Inc., 1121 East 3900 South, Salt Lake City, UT 84124, USA.
Abstract
AIM: Toxicokinetic and pharmacokinetic studies of therapeutic oligonucleotides require validated bioanalytical methods for sensitive and specific quantification of oligonucleotide drug candidates in biological samples. RESULTS: A peptide nucleic acid (PNA) hybridization-based HPLC-fluorescence assay was developed and validated for quantification of Arrowhead Pharmaceuticals' proprietary siRNA in rat plasma samples via hybridization and anion-exchange-HPLC (AEX-HPLC) with fluorescence detection. CONCLUSION: The validated method provided a sensitive and selective approach for quantification of siRNA in biological samples at a linear quantitation range of 1-1000 ng/ml. The assay requires only 25 μl of plasma sample and shows excellent accuracy and precision even without using an internal standard, providing a useful quantification method for siRNA determination in biological matrix with limited sample volume.
AIM: Toxicokinetic and pharmacokinetic studies of therapeutic oligonucleotides require validated bioanalytical methods for sensitive and specific quantification of oligonucleotide drug candidates in biological samples. RESULTS: A peptide nucleic acid (PNA) hybridization-based HPLC-fluorescence assay was developed and validated for quantification of Arrowhead Pharmaceuticals' proprietary siRNA in rat plasma samples via hybridization and anion-exchange-HPLC (AEX-HPLC) with fluorescence detection. CONCLUSION: The validated method provided a sensitive and selective approach for quantification of siRNA in biological samples at a linear quantitation range of 1-1000 ng/ml. The assay requires only 25 μl of plasma sample and shows excellent accuracy and precision even without using an internal standard, providing a useful quantification method for siRNA determination in biological matrix with limited sample volume.
Authors: Bruno M D C Godinho; James W Gilbert; Reka A Haraszti; Andrew H Coles; Annabelle Biscans; Loic Roux; Mehran Nikan; Dimas Echeverria; Matthew Hassler; Anastasia Khvorova Journal: Nucleic Acid Ther Date: 2017-10-12 Impact factor: 5.486
Authors: Christian Berk; Gianluca Civenni; Yuluan Wang; Christian Steuer; Carlo V Catapano; Jonathan Hall Journal: Nucleic Acid Ther Date: 2020-04-20 Impact factor: 5.486
Authors: François Halloy; Pavithra S Iyer; Paulina Ćwiek; Alice Ghidini; Jasmin Barman-Aksözen; Nicole Wildner-Verhey van Wijk; Alexandre P A Theocharides; Elisabeth I Minder; Xiaoye Schneider-Yin; Daniel Schümperli; Jonathan Hall Journal: Nucleic Acids Res Date: 2020-05-21 Impact factor: 16.971
Authors: Worapol Ngamcherdtrakul; Moataz Reda; Molly A Nelson; Ruijie Wang; Husam Y Zaidan; Daniel S Bejan; Ngoc Ha Hoang; Ryan S Lane; Shiuh-Wen Luoh; Sancy A Leachman; Gordon B Mills; Joe W Gray; Amanda W Lund; Wassana Yantasee Journal: Adv Mater Date: 2021-06-12 Impact factor: 32.086